IMI2-2015-07-04
IMI2-2015-07-04
1 project · €8,025,000 total EU contribution (project-level) · 19 participating organizations · 6 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€8,025,000
Countries active
Participant organizations by country (headquarters in CORDIS).
- France (5)
- Germany (4)
- UK (4)
- CH (2)
- Netherlands (2)
- PT (2)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- AIBILI ASSOCIACAO PARA INVESTIGACAO BIOMEDICA E INNOVACAO EM LUZ E IMAGEM1 projects · PT
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1 projects · FR
- BAYER AKTIENGESELLSCHAFT1 projects · DE
- CARL ZEISS MEDITEC AG1 projects · DE
- CENTRE HOSPITALIER NATIONAL D'OPHTALMOLOGIE DES QUINZE-VINGTS1 projects · FR
- CITY1 projects · UK
- ECRIN1 projects · FR
- ROCHE1 projects · CH
- FONDATION VOIR ET ENTENDRE1 projects · FR
- NETWORK OF COORDINATING CENTRES FOR CLINICAL TRIALS1 projects · DE
- MOORFIELDS EYE HOSPITAL NHS FOUNDATION TRUST1 projects · UK
- NOVARTIS1 projects · CH
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076 MACUSTAR · 116076 | H2020 | €8,025,000 | €0 | Details |